Episode 1 of DISCOVER SM – a podcast series developed for international HCPs to increase awareness of systemic mastocytosis (SM). This episode provides an introduction to SM, exploring its origins, key features, and subtypes. Expert insights highlight how the understanding of SM has evolved over time, setting the foundation for recognising and diagnosing this rare disease.
For more information on SM, visit our Discover SM website.
1. Gülen T, et al. J Intern Med. 2016;279(3):211–228.
2. Ungerstedt J, et al. Cancers (Basel). 2022;14(16):3942.
3. Valent P, et al. Cancer Res. 2017;77(6):1261–1270.
4. Rare Disease Advisor. Systemic Mastocytosis History. Available at: https://www.rarediseaseadvisor.com/hcp-resource/systemic-mastocytosis-history/. Last accessed October 2025.
5. Jensen RT. Hematol Oncol Clin North Am. 2000;14(3):579-623.
6. Theoharides TC, et al. N Engl J Med. 2015;373(2):163–172.
7. Gilreath JA, et al. Clin Pharmacol. 2019;11:77–92.
8. Pyatilova P, et al. World Allergy Organ J. 2023;16(11):100838.
9. Universitätsklinik für Innere Medizin I. Reference Centers. Available at:https://innere-med-1.meduniwien.ac.at/unsere-klinischen-abteilungen/haematologie-und-haemostaseologie/projekte/ecnm-registry-european-competence-network-mastocytosis/centers/reference-centers/. Last accessed October 2025.
10. Valent P, et al. J Allergy Clin Immunol Pract. 2022;10(8):1999–2012.e6.
11. Berezowska S, et al. Mod Pathol. 2014;27(1):19–29.
12. Valent P, et al. Hemasphere. 2021;5(11):e646.
13. Arber DA, et al. Blood. 2022;140(11):1200–1228.
14. Khoury JD, et al. Leukemia. 2022;36(7):1703–1719.
15. Pardanani A. Am J Hematol. 2023;98(7):1097–1116.
16. Veitch S, Radia DH. Diagnostics (Basel). 2023;14(1):80.
17. Levedahl KH, et al. Eur J Oncol Nurs. 2022:60:102172.
18. Triggiani M, et al. Clin Exp Allergy. 2025;55(9):784–794.
19. Jennings SV,
et al.
Immunol Allergy Clin North Am. 2018;38(3):505–525.
INTBP-DAXSM-25.021, 10/2025
